Reduced gastric acidity, proton pump inhibitors and increased severity of COVID-19 infections
Open Access
- 18 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 25 (1), 1-2
- https://doi.org/10.1186/s13054-021-03497-6
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infectionDigestive and Liver Disease, 2020
- Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort StudyGastroenterology, 2020
- Could the severity of COVID-19 be increased by low gastric acidity?Critical Care, 2020
- Factors affecting stability and infectivity of SARS-CoV-2Journal of Hospital Infection, 2020